Summary

The speaking valves market is valued at an estimated USD 94 million in 2024 and is projected to reach USD 128 million by 2029 at a CAGR of 6.4% during the forecast period. With increase in tracheostomy and laryngectomy surgeries the speaking valves market is expected to grow as speaking valve is placed on patients finding it difficult to communicate after these surgeries, so speaking valve helps in bring back the speech and facilitating communication. By facilitating communication, it makes great positive impact on mental health which helps in fast recovery. Additionally, government and private players continuously trying to raise awareness and knowledge about speaking valves and ensuring that they are readily available to the people who need them. Such initiatives are expected to increase the use of speaking valves in the coming years.
“Silicone segment accounted for the highest growth rate in the speaking valves market, during the forecast period.”
Based on Material, the speaking valves market is bifurcated into silicone, PVC and other materials. The silicone segment in the speaking valves market is experiencing substantial growth. Silicone speaking valves are the preferred choice because of their biocompatibility. They offer comfort, safety, durability, and hygienic properties, making them a reliable option for patients.
The tracheostomy patient experience extreme discomfort In order to cater to this need, there are medical devices such as speaking valves which provide comfort to the patients due to its material. Silicone speaking valves are biocompatible, hence compatible with the human tissue, thereby reducing adverse body reactions and ensuring safety in case of extended exposure to sensitive parts of the body. Silicone can withstand extreme temperatures and endure exposure to chemicals without degradation, thus being reliable under numerous conditions. Not to forget, its unparalleled flexibility allows silicone to produce precisely molded valves to meet individual needs, proving them to be the best available product in the market.
“Hospitals segment is expected to have the fastest growth rate in the speaking valves market, by end user, during the forecast period.”
The speaking valves market is segmented into hospitals, ambulatory surgical centers and other end users, based on end user. Hospitals segment is expected to account for the highest CAGR during the forecast period. This growth can be attributed to factors like the high preference for hospital-based treatment, increasing investments in healthcare infrastructure, and the presence of the specialized expertise required for placement of speaking valves. These factors can account for the growth of this segment.
“Asia Pacific: The fastest-growing region in speaking valves market.”
The worldwide market for speaking valves is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to experience the most substantial growth in the forecast period. In Asia Pacific region, there is a significant increase in chronic illnesses like respiratory problems, cancer, and neurological disorders in the area, leading to a higher demand for tracheostomies resulting in increased market for speaking valves. Moreover, governments in the region are making substantial investments in healthcare infrastructure and technology and in countries like India government is providing favourable reimbursement to boost facilitate access to healthcare. This confluence of factors is propelling the speaking valves market within the Asia Pacific region.
The break-up of the profile of primary participants in the speaking valves market:
• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4%
The key players in this market are Coloplast A/S (Denmark), Freudenberg Group (Germany), Passy-Muir, Inc. (USA), Primed Halberstadt Medizintechnik GmbH (Germany), Medtronic (Ireland), Teleflex Incorporated (US), Andreas Fahl Medizintechnik-Vertrieb GmbH (Germany), Pepper Medical (US), Boston Medical Products Inc. (US), Parburch Medical Developments Ltd. (England), Besmed Health Business Corp (Taiwan), E. Benson Hood Laboratories, Inc. (US), The Airway Company (US), Prunus Medical (China), Mednom (South Africa), Insight Medical Products Ltd (UK), Ashton India Private Limited (India).
Research Coverage:
This research report categorizes the speaking valves market by material (Silicone, PVC and other materials), by application (tracheostomy, laryngectomy and other applications), by end user (hospitals, ambulatory surgical centers and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the speaking valves market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the speaking valves market. Competitive analysis of upcoming startups in the speaking valves market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall speaking valves market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (increasing number of tracheostomy and laryngectomy procedures, technological advancements, Favourable reimbursement scenario and the rising patient demand for ICUs and ambulatory care), opportunities (Emerging markets), restraints (High cost of tracheostomy procedure), and challenges (lack of awareness about speaking valves, and dearth of skilled surgeon) influencing the growth of the speaking valves market.
• Product Development/Innovation: Detailed insights research & development activities, and new product launches in the speaking valves market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the speaking valves market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the speaking valves market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Coloplast A/S (Denmark), Freudenberg Group (Germany), Passy-Muir, Inc. (USA), Primed Halberstadt Medizintechnik GmbH (Germany), and Medtronic (Ireland).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 19
1.1 STUDY OBJECTIVES 19
1.2 MARKET DEFINITION 19
1.2.1 INCLUSIONS & EXCLUSIONS 20
1.3 MARKETS COVERED 20
1.3.1 YEARS CONSIDERED 21
1.4 CURRENCY CONSIDERED 21
1.5 STUDY LIMITATIONS 21
1.6 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
2.2 RESEARCH APPROACH 23
2.2.1 SECONDARY DATA 24
2.2.1.1 Key data from secondary sources 24
2.2.2 PRIMARY DATA 25
2.2.2.1 Primary sources 26
2.2.2.2 Key data from primary sources 26
2.2.2.3 Key industry insights 27
2.2.2.4 Breakdown of primary interviews 27
2.3 MARKET SIZE ESTIMATION 28
2.3.1 BOTTOM-UP APPROACH 29
2.3.1.1 Approach 1: Company revenue estimation approach 29
2.3.1.2 Approach 2: Presentations of companies and primary interviews 29
2.3.1.3 Growth forecast 30
2.3.1.4 CAGR projections 30
2.3.2 TOP-DOWN APPROACH 30
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 32
2.5 MARKET SHARE ANALYSIS 33
2.6 STUDY ASSUMPTIONS 33
2.7 RISK ASSESSMENT 33
2.7.1 RISK ASSESSMENT: SPEAKING VALVES MARKET 33
3 EXECUTIVE SUMMARY 34

4 PREMIUM INSIGHTS 37
4.1 SPEAKING VALVES MARKET OVERVIEW 37
4.2 SPEAKING VALVES MARKET SHARE, BY MATERIAL, 2024 VS. 2029 38
4.3 SPEAKING VALVES MARKET SHARE, BY APPLICATION, 2024 VS. 2029 38
4.4 SPEAKING VALVES MARKET SHARE, BY END USER, 2024 VS. 2029 39
4.5 SPEAKING VALVES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Increasing number of tracheostomy and laryngectomy procedures 41
5.2.1.2 Technological advancements 42
5.2.1.3 Favorable reimbursement scenario 42
5.2.1.4 Rising patient demand for ICUs and ambulatory care 42
5.2.2 RESTRAINTS 43
5.2.2.1 High cost of tracheostomy procedures 43
5.2.3 OPPORTUNITIES 43
5.2.3.1 Emerging markets 43
5.2.4 CHALLENGES 43
5.2.4.1 Lack of awareness in emerging countries 43
5.2.4.2 Dearth of skilled surgeons 44
5.3 PRICING ANALYSIS 45
5.3.1 AVERAGE SELLING PRICE OF SPEAKING VALVES, BY REGION 45
5.4 PATENT ANALYSIS 46
5.4.1 LIST OF MAJOR PATENTS 47
5.5 VALUE CHAIN ANALYSIS 48
5.6 SUPPLY CHAIN ANALYSIS 49
5.7 TRADE ANALYSIS 50
5.7.1 TRADE ANALYSIS 50
5.8 ECOSYSTEM ANALYSIS 50
5.9 PORTER’S FIVE FORCES ANALYSIS 52
5.9.1 THREAT OF NEW ENTRANTS 53
5.9.2 THREAT OF SUBSTITUTES 53
5.9.3 BARGAINING POWER OF BUYERS 53
5.9.4 BARGAINING POWER OF SUPPLIERS 53
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 53
5.10 REGULATORY LANDSCAPE 53
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 54
5.10.2 REGULATORY SCENARIO 55
5.10.2.1 North America 55
5.10.2.1.1 US 55
5.10.2.1.2 Canada 56
5.10.2.2 Europe 56
5.10.2.3 Asia Pacific 56
5.10.2.3.1 China 56
5.10.2.3.2 Japan 56
5.10.2.4 Latin America 57
5.10.2.4.1 Brazil 57
5.10.2.4.2 Mexico 57
5.10.2.5 Middle East 58
5.10.2.6 Africa 58
5.11 KEY CONFERENCES & EVENTS IN 2024–2025 58
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 59
5.12.1 REVENUE SHIFT AND REVENUE POCKETS FOR SPEAKING VALVE MANUFACTURERS 59
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 60
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 60
5.13.2 BUYING CRITERIA 61
5.14 INVESTMENT & FUNDING SCENARIO 62
5.15 CASE STUDY ANALYSIS 62
5.15.1 CASE STUDY: SPEAKING VALVE IMPROVES QUALITY OF LIFE FOR TRACHEOSTOMY PATIENT 62
5.16 IMPACT OF ARTIFICIAL INTELLIGENCE ON SPEAKING VALVES MARKET 63
6 SPEAKING VALVES MARKET, BY MATERIAL 65
6.1 INTRODUCTION 66
6.2 SILICONE 66
6.2.1 BIOCOMPATIBLE ADVANTAGE OF SILICONE FOR IMPROVED SPEAKING VALVE PERFORMANCE TO BOOST MARKET GROWTH 66
6.3 PVC 68
6.3.1 LOW COST OF PVC TO SUPPORT MARKET ADOPTION 68
6.4 OTHER MATERIALS 70
7 SPEAKING VALVES MARKET, BY APPLICATION 74
7.1 INTRODUCTION 75
7.2 TRACHEOSTOMY 75
7.2.1 INCREASING NUMBER OF TRACHEOSTOMY PROCEDURES PERFORMED TO DRIVE MARKET GROWTH 75
7.3 LARYNGECTOMY 77
7.3.1 GROWING ROLE OF SPEAKING VALVES IN LARYNGECTOMY RECOVERY TO SUPPORT GROWTH 77
7.4 OTHER APPLICATIONS 79

8 SPEAKING VALVES MARKET, BY END USER 83
8.1 INTRODUCTION 84
8.2 HOSPITALS 84
8.2.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH 84
8.3 AMBULATORY SURGICAL CENTERS 87
8.3.1 COST-EFFECTIVENESS OF AMBULATORY SURGICAL CENTERS COMPARED TO HOSPITAL SETTINGS TO FAVOR GROWTH 87
8.4 OTHER END USERS 89
9 SPEAKING VALVES MARKET, BY REGION 92
9.1 INTRODUCTION 93
9.2 NORTH AMERICA 93
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 96
9.2.2 US 96
9.2.2.1 US to dominate market in North America during forecast period 96
9.2.3 CANADA 98
9.2.3.1 Favorable government investments to augment market growth 98
9.3 EUROPE 100
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 102
9.3.2 GERMANY 102
9.3.2.1 Germany to command largest share of speaking valves market in Europe 102
9.3.3 UK 104
9.3.3.1 Increasing government initiatives and support to aid market 104
9.3.4 FRANCE 106
9.3.4.1 Favorable health insurance system to drive market growth 106
9.3.5 ITALY 108
9.3.5.1 Well-established healthcare infrastructure to support market 108
9.3.6 SPAIN 110
9.3.6.1 Increasing incidence of COPD to fuel market growth 110
9.3.7 REST OF EUROPE 111
9.4 ASIA PACIFIC 113
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 116
9.4.2 CHINA 116
9.4.2.1 Large patient population and healthcare infrastructure improvements to drive market growth in China 116
9.4.3 JAPAN 118
9.4.3.1 Favorable reimbursement policies and supportive regulatory environment to aid market 118
9.4.4 INDIA 120
9.4.4.1 Availability of skilled personnel and low treatment costs to favor market growth 120
9.4.5 REST OF ASIA PACIFIC 122
9.5 LATIN AMERICA 123
9.5.1 INCREASING GERIATRIC POPULATION TO PROPEL MARKET 123
9.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 125
9.6 MIDDLE EAST & AFRICA 125
9.6.1 INFRASTRUCTURAL IMPROVEMENTS TO CONTRIBUTE TO MARKET GROWTH 125
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 127
10 COMPETITIVE LANDSCAPE 128
10.1 INTRODUCTION 128
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 128
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SPEAKING VALVES MARKET 128
10.3 REVENUE ANALYSIS 129
10.4 MARKET SHARE ANALYSIS 130
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 132
10.5.1 STARS 132
10.5.2 EMERGING LEADERS 132
10.5.3 PERVASIVE PLAYERS 132
10.5.4 PARTICIPANTS 132
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 134
10.5.5.1 Company footprint 134
10.5.5.2 Material footprint 134
10.5.5.3 Application footprint 135
10.5.5.4 Region footprint 136
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 136
10.6.1 PROGRESSIVE COMPANIES 136
10.6.2 RESPONSIVE COMPANIES 136
10.6.3 DYNAMIC COMPANIES 137
10.6.4 STARTING BLOCKS 137
10.6.5 COMPETITIVE BENCHMARKING: STARTUP/SME PLAYERS, 2023 138
10.7 COMPANY VALUATION & FINANCIAL METRICS 139
10.8 BRAND/PRODUCT COMPARISON 140
10.8.1 MEDTRONIC 140
10.8.2 PASSY-MUIR, INC. 140
10.8.3 FREUDENBERG GROUP 141
10.9 COMPETITIVE SCENARIO 141
10.9.1 PRODUCT LAUNCHES 141
10.9.2 DEALS 141

11 COMPANY PROFILES 142
11.1 KEY PLAYERS 142
11.1.1 COLOPLAST A/S 142
11.1.1.1 Business overview 142
11.1.1.2 Products offered 144
11.1.1.3 Recent developments 144
11.1.1.3.1 Deals 144
11.1.1.4 MnM view 144
11.1.1.4.1 Right to win 144
11.1.1.4.2 Strategic choices 145
11.1.1.4.3 Weaknesses & competitive threats 145
11.1.2 FREUDENBERG GROUP 146
11.1.2.1 Business overview 146
11.1.2.2 Products offered 147
11.1.2.3 Recent developments 147
11.1.2.3.1 Product launches 147
11.1.2.4 MnM view 148
11.1.2.4.1 Right to win 148
11.1.2.4.2 Strategic choices 148
11.1.2.4.3 Weaknesses & competitive threats 148
11.1.3 PASSY-MUIR, INC. 149
11.1.3.1 Business overview 149
11.1.3.2 Products offered 149
11.1.3.3 MnM view 150
11.1.3.3.1 Right to win 150
11.1.3.3.2 Strategic choices 150
11.1.3.3.3 Weaknesses & competitive threats 150
11.1.4 PRIMED HALBERSTADT MEDIZINTECHNIK GMBH 151
11.1.4.1 Business overview 151
11.1.4.2 Products offered 151
11.1.5 MEDTRONIC 153
11.1.5.1 Business overview 153
11.1.5.2 Products offered 154
11.1.6 TELEFLEX INCORPORATED 155
11.1.6.1 Business overview 155
11.1.6.2 Products offered 156
11.1.7 ANDREAS FAHL MEDIZINTECHNIK-VERTRIEB GMBH 157
11.1.7.1 Business overview 157
11.1.7.2 Products offered 157
11.1.8 BOSTON MEDICAL PRODUCTS INC. 159
11.1.8.1 Business overview 159
11.1.8.2 Products offered 159
11.1.9 PEPPER MEDICAL 160
11.1.9.1 Business overview 160
11.1.9.2 Products offered 160
11.1.10 PARBURCH MEDICAL DEVELOPMENTS LTD. 161
11.1.10.1 Business overview 161
11.1.10.2 Products offered 161
11.2 OTHER PLAYERS 162
11.2.1 THE AIRWAY COMPANY 162
11.2.2 BESMED HEALTH BUSINESS CORP. 162
11.2.3 PRUNUS MEDICAL 163
11.2.4 MEDNOM 163
11.2.5 INSIGHT MEDICAL PRODUCTS LTD. 164
11.2.6 E. BENSON HOOD LABORATORIES, INC. 164
11.2.7 ASHTON INDIA PRIVATE LIMITED 165
12 APPENDIX 166
12.1 DISCUSSION GUIDE 166
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 170
12.3 CUSTOMIZATION OPTIONS 172
12.4 RELATED REPORTS 172
12.5 AUTHOR DETAILS 173